Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...

Jupiter Hospital, Baner has launched a dedicated Guillain-Barré Syndrome (GBS) Clinic to enhance early diagnosis, treatment, ...

KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...

After GBS outbreak in Madhya Pradesh’s Neemuch district, doctors explain how the immunological disorder presents in children, ...

Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), for Guillain-Barré Syndrome (GBS). GBS is a neuromuscular emergency affecting ...

Currently, there is no known way to prevent GBS. However, getting vaccinated against certain infections and practising good ...

Imagine waking up with a slight tingling in the feet, only to find ourselves completely paralyzed within days. This is the terrifying reality of Guillain-Barré Syndrome (GBS), a rare but serious ...

Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...

Dallas Cowboys All-Pro center Travis Frederick missed the entire 2018 season after being diagnosed with Guillain-Barré Syndrome, a rare autoimmune disease. It was caught in the early stages, Frederick ...